Johnson & Johnson asks FDA to authorize booster shot of its Covid vaccine and the extra doses could be rolled out as soon as next week

Johnson & Johnson asked the U.S. Food and Drug Administration (FDA) on Tuesday to authorize a booster shot of its COVID-19 vaccine.

The New Brunswick, New Jersey-based company said it filed a request with the FDA to authorize boosters for Americans aged 18 and older.

While J&J said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators.

Last month, the FDA authorized booster shots of Pfizer’s vaccine for older Americans and other groups with heightened vulnerability to COVID-19.

It’s part of a sweeping effort by the Biden administration to shore up protection amid the Delta variant and potential waning vaccine immunity.

Click here to read more.
Source: Daily Mail